Concentric Analgesics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$20M
- Investors
-
8
Concentric Analgesics General Information
Description
Developer of novel and non-opioid therapeutics designed to offer pain relief after a single local administration. The company's therapeutics target pain at the source with limited systematic exposure and reliefs without numbness or weakness during surgery, enabling medical professionals to simplify ongoing care and adherence, improve outcomes, and reduce the intensity of care for osteoarthritis patients.
Contact Information
Website
www.concentricanalgesics.comCorporate Office
- 101 California Street
- Suite 1210
- San Francisco, CA 94111
- United States
Corporate Office
- 101 California Street
- Suite 1210
- San Francisco, CA 94111
- United States
Concentric Analgesics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 16-Dec-2021 | $20M | 00000 | Completed | Clinical Trials - Phase 2 | |
| 4. Debt - PPP | 29-Apr-2020 | 000.00 | Completed | Clinical Trials - Phase 2 | ||
| 3. Later Stage VC (Series B) | 21-May-2019 | 0000 | 000.00 | 00000 | Completed | Clinical Trials - Phase 2 |
| 2. Early Stage VC (Series A) | 06-Dec-2016 | $8.36M | $8.36M | 000.00 | Completed | Startup |
| 1. Accelerator/Incubator | Completed | Startup |
Concentric Analgesics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 0,000,000 | 00.000000 | 00.0 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Concentric Analgesics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Concentric Analgesics Patents
Concentric Analgesics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4294389-A1 | Trpm8 agonists as cooling agents and for the treatment of disease | Pending | 17-Feb-2021 | 00000000000 | |
| US-20240199564-A1 | Trpm8 agonists as cooling agents and for the treatment of disease | Pending | 17-Feb-2021 | 00000000000 | |
| EP-4263495-A1 | Pharmaceutical formulations of a phenolic trpv1 agonist prodrug | Pending | 14-Dec-2020 | 0000000000 | |
| EP-4263496-A1 | Prodrug of a phenolic trpv1 agonist for the treatment of pain | Pending | 14-Dec-2020 | 0000000000 | |
| EP-4259136-A1 | Crystalline form of a phenolic trpv1 agonist prodrug | Pending | 14-Dec-2020 | C07D211/26 |
Concentric Analgesics Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Frank Bellizzi Jr. | Chief Executive Officer & Board Member | |
| John Donovan MD | Co-Founder, Chief Scientific Officer, President & Board Member | |
| Craig Husfeld Ph.D | Co-Founder & Vice President of Medicinal Chemistry & Research |
Concentric Analgesics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Frank Bellizzi Jr. | Concentric Analgesics | Chief Executive Officer & Board Member | 000 0000 |
| John Donovan MD | Concentric Analgesics | Co-Founder, Chief Scientific Officer, President & Board Member | 000 0000 |
| Jonathan Lynch | Self | Board Member | 000 0000 |
| Paul Carter | Self | Board Member | 000 0000 |
| Thomas King | Self | Chairman | 000 0000 |
Concentric Analgesics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Concentric Analgesics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| James Toussaint | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Richard Del Bello | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Cowen Healthcare Investments | Venture Capital | Minority | 000 0000 | 000000 0 |
| Gravitas Americas | Venture Capital | Minority | 000 0000 | 000000 0 |
| Jay Kern | Angel (individual) | Minority | 000 0000 | 000000 0 |
Concentric Analgesics FAQs
-
When was Concentric Analgesics founded?
Concentric Analgesics was founded in 2014.
-
Who is the founder of Concentric Analgesics?
John Donovan MD and Craig Husfeld Ph.D are the founders of Concentric Analgesics.
-
Who is the CEO of Concentric Analgesics?
Frank Bellizzi Jr. is the CEO of Concentric Analgesics.
-
Where is Concentric Analgesics headquartered?
Concentric Analgesics is headquartered in San Francisco, CA.
-
What is the size of Concentric Analgesics?
Concentric Analgesics has 19 total employees.
-
What industry is Concentric Analgesics in?
Concentric Analgesics’s primary industry is Drug Discovery.
-
Is Concentric Analgesics a private or public company?
Concentric Analgesics is a Private company.
-
What is Concentric Analgesics’s current revenue?
The current revenue for Concentric Analgesics is 000000.
-
How much funding has Concentric Analgesics raised over time?
Concentric Analgesics has raised $104M.
-
Who are Concentric Analgesics’s investors?
James Toussaint, Richard Del Bello, Cowen Healthcare Investments, Gravitas Americas, and Jay Kern are 5 of 8 investors who have invested in Concentric Analgesics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
